Nichols Management Group has been the driving force behind many of the most successful ventures in laboratory mergers, acquisitions and other forms of collaboration.
NMG is an industry expert in laboratory mergers, acquisitions, divestitures and partnering services. NMG has been utilized by venture capital companies and corporations to perform due diligence on potential targets. Due diligence capabilities include third-party evaluations of the outlook, relative position and value of potential candidates for acquisition, divestiture or strategic alliance.
NMG has maintained close ties with the medical venture capital community recommending and implementing the formation of new companies as well as staying abreast of developments throughout the medical industry.
Our company also serves as a finder and identifies and vets candidates utilizing our resources as well as a proprietary database to identify and target clinical and anatomic laboratories throughout the United States.
Since 1989, NMG has performed due diligence studies with a combined transaction value of more than $1 Billion.
NMG concentrates its considerable resources on disseminating information to serve individual and corporate investors, other healthcare providers.